Bill Foster
AnalysisD IL-11 · House
Vote dates filter recorded votes and vote-linked bills; sponsorship remains included.
Policy Effects
Estimated effects on people, organizations, and industries in bills this legislator sponsored, cosponsored, or voted on. Includes bills they voted against.
These are assessments of legislative text, not measurements of realized outcomes or the legislator’s intent.
This selection could not be loaded. Your current view is still available.
Open the requested selection in a full pageWorkforce Development: affected groups
1 identified effect across 1 analyzed clause in 1 bill.
Numbers count identified effects. One clause can affect several groups or contain several effects.
What the effects and counts mean
Potential benefits are effects assessed as favorable to the named group. Potential burdens impose costs, restrictions, risks, or lost opportunities on that group.
Mixed effects contain countervailing effects on the same group. Unclear effects have an undetermined direction. A group can have separate benefits and burdens; these are counted separately.
Counts describe the number of identified effects, not their size or public value. Bill and clause counts are distinct within each view. Shared evidence may appear under several groups or policy areas, so their counts should not be added together.
Historical bill versions are included. Clauses analyzed in different versions count separately. A bill’s current status does not establish that every analyzed provision was enacted.
Only direct effects with high or medium confidence in the policy-area assignment are included. Bills are connected through sponsorship, cosponsorship, or Yea/Nay votes; a vote against a bill does not reverse its assessed effects. Vote dates filter recorded votes and vote-linked bills; sponsorship remains included.
Loading votes...
Sponsored & Cosponsored Bills
hr9941-119
Cosponsor In CommitteeRight to IVF Act of 2026
hr9902-119
Primary Sponsor In CommitteeFederal Naming Standards Act
hr9803-119
Primary Sponsor In CommitteeProtecting Immigrants From Legal Exploitation Act of 2026
hr9740-119
Primary Sponsor In CommitteeCritical Materials Processing Technology Testbed Act
hres1432-119
Cosponsor In CommitteeOf inquiry requesting the President and directing the Secretary of Health and Human Services to transmit, respectively, certain documents to the House of Representatives relating to the freeze on State-based Temporary Assistance for Needy Families, Child Care and Development Fund, and Social Services Block Grant payments for California, Colorado, Illinois, Minnesota, and New York.
hr9676-119
Primary Sponsor In CommitteeExamining Opioid Treatment Infrastructure Act of 2026
hr9675-119
Primary Sponsor In CommitteeExpanding Opportunities for Recovery Act of 2026
hres1417-119
Cosponsor In CommitteeRemembering the lives lost and honoring the survivors 4 years after the Independence Day Parade shooting that occurred on July 4, 2022, in Highland Park, Illinois.
hr9463-119
Primary Sponsor In CommitteeNational Fab Lab Network Act of 2026
hr9462-119
Primary Sponsor In CommitteeInvestor Choice Act of 2026
hr9370-119
Cosponsor In CommitteeProtect Local Funding Act
hr9259-119
Cosponsor In CommitteeFair Day in Court for Kids Act of 2026
hr9272-119
Primary Sponsor In CommitteeParent PLUS Loan Fairness and Responsibility Act of 2026
hr9144-119
Primary Sponsor In CommitteeClosing the Digital Divide for Students Act of 2026
hr9124-119
Primary Sponsor In CommitteeKnow Your Rights Act
hjres189-119
Cosponsor In CommitteeProviding for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations".
hr8969-119
Primary Sponsor In CommitteeNuclear Forensics Authority Realignment Act
hr8914-119
Cosponsor In CommitteeNo Taxpayer-Funded Settlement Slush Funds Act of 2026
hr8831-119
Cosponsor In CommitteeProtecting Our Democracy Act
hres1285-119
Cosponsor In CommitteeExpressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Loading countries...
Select a clause to see detailed analysis
Failed to load analysis
Please try again
Failed to load clauses
Please try again
Explore affected groups in Policy Effects to view supporting evidence. Existing clause links also open here.
Select a clause to see detailed analysis